Markus Pirklbauer

768 total citations
33 papers, 462 citations indexed

About

Markus Pirklbauer is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Markus Pirklbauer has authored 33 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 6 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Markus Pirklbauer's work include Dialysis and Renal Disease Management (6 papers), Parathyroid Disorders and Treatments (5 papers) and Diabetes Treatment and Management (4 papers). Markus Pirklbauer is often cited by papers focused on Dialysis and Renal Disease Management (6 papers), Parathyroid Disorders and Treatments (5 papers) and Diabetes Treatment and Management (4 papers). Markus Pirklbauer collaborates with scholars based in Austria, Australia and Italy. Markus Pirklbauer's co-authors include Gert Mayer, Herbert Schramek, Gert Mayer, Johannes Leierer, Andreas Kronbichler, Michael Rudnicki, Paul Perco, Martin Tiefenthaler, Susanne Kaser and Andrea Griesmacher and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Markus Pirklbauer

30 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Pirklbauer Austria 15 135 130 89 88 79 33 462
Ernest Suresh Singapore 12 78 0.6× 97 0.7× 33 0.4× 78 0.9× 74 0.9× 35 532
Peale Chuang United States 11 155 1.1× 99 0.8× 49 0.6× 122 1.4× 83 1.1× 15 733
Pablo Íñigo Spain 11 92 0.7× 156 1.2× 43 0.5× 129 1.5× 202 2.6× 22 583
Taner Demirci Türkiye 13 83 0.6× 60 0.5× 146 1.6× 79 0.9× 26 0.3× 53 465
Panagiotis Pateinakis Greece 10 208 1.5× 57 0.4× 20 0.2× 65 0.7× 52 0.7× 32 410
Lara Matilla Spain 12 50 0.4× 86 0.7× 38 0.4× 73 0.8× 67 0.8× 23 367
Marianne Wigger Germany 11 146 1.1× 81 0.6× 20 0.2× 83 0.9× 67 0.8× 24 505
Nancy Wassef United Kingdom 7 123 0.9× 284 2.2× 16 0.2× 49 0.6× 61 0.8× 23 455
Hiromichi Yoshizawa Japan 11 257 1.9× 183 1.4× 47 0.5× 83 0.9× 77 1.0× 25 534
Wencong Guo China 7 55 0.4× 132 1.0× 35 0.4× 38 0.4× 32 0.4× 20 428

Countries citing papers authored by Markus Pirklbauer

Since Specialization
Citations

This map shows the geographic impact of Markus Pirklbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Pirklbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Pirklbauer more than expected).

Fields of papers citing papers by Markus Pirklbauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Pirklbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Pirklbauer. The network helps show where Markus Pirklbauer may publish in the future.

Co-authorship network of co-authors of Markus Pirklbauer

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Pirklbauer. A scholar is included among the top collaborators of Markus Pirklbauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Pirklbauer. Markus Pirklbauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andò, Sebastiano, Markus Pirklbauer, Marcus D. Säemann, et al.. (2024). Renin–Angiotensin–Aldosterone System: From History to Practice of a Secular Topic. International Journal of Molecular Sciences. 25(7). 4035–4035. 25 indexed citations
2.
Kurnikowski, Amelie, Elisabeth Schwaiger, Sebastian Hödlmoser, et al.. (2024). Patient and Caregiver Perspectives on Gender Disparity in CKD. Kidney360. 6(2). 227–235. 1 indexed citations
3.
4.
5.
Kurnikowski, Amelie, Philipp Gauckler, Markus Pirklbauer, et al.. (2024). Patient and Caregiver Perspectives on Gender Disparity in Chronic Kidney Disease: Questionnaire Survey, Based on an Interview Study. American Journal of Nephrology. 55(5). 561–582. 4 indexed citations
6.
Eichhorn, Tanja, Silke Huber, René Weiss, et al.. (2023). Infection with SARS-CoV-2 Is Associated with Elevated Levels of IP-10, MCP-1, and IL-13 in Sepsis Patients. Diagnostics. 13(6). 1069–1069. 8 indexed citations
7.
Kurnikowski, Amelie, Elisabeth Schwaiger, Marlies Antlanger, et al.. (2022). Chronic kidney disease is more prevalent among women but more men than women are under nephrological care. Wiener klinische Wochenschrift. 135(3-4). 89–96. 31 indexed citations
8.
Pirklbauer, Markus, et al.. (2022). The Tangential Extraperitoneal Retrorenal Approach in Kidney Transplant Biopsy: An Observational Study to Assess Complication and Adequacy Rates. Transplant International. 35. 10068–10068. 4 indexed citations
9.
Pirklbauer, Markus. (2021). Anti-inflammatory potential of Empagliflozin. Inflammopharmacology. 29(2). 573–576. 13 indexed citations
10.
Pirklbauer, Markus, David A. Bushinsky, Peter Kotanko, & Gudrun Schappacher‐Tilp. (2021). Personalized Prediction of Short- and Long-Term PTH Changes in Maintenance Hemodialysis Patients. Frontiers in Medicine. 8. 704970–704970. 4 indexed citations
11.
Pirklbauer, Markus, et al.. (2021). Empagliflozin Inhibits IL-1β-Mediated Inflammatory Response in Human Proximal Tubular Cells. International Journal of Molecular Sciences. 22(10). 5089–5089. 19 indexed citations
12.
Pirklbauer, Markus, et al.. (2020). Intradialytic Calcium Kinetics and Cardiovascular Disease in Chronic Hemodialysis Patients. Blood Purification. 49(6). 723–732. 5 indexed citations
13.
Pirklbauer, Markus, et al.. (2020). Prophylactic Ligature of AV Fistula Prevents High Output Heart Failure after Kidney Transplantation. American Journal of Nephrology. 51(7). 511–519. 20 indexed citations
14.
Pirklbauer, Markus, et al.. (2020). Empagliflozin Inhibits Basal and IL-1β-Mediated MCP-1/CCL2 and Endothelin-1 Expression in Human Proximal Tubular Cells. International Journal of Molecular Sciences. 21(21). 8189–8189. 24 indexed citations
15.
Neuwirt, Hannes, Michael Rudnicki, Peter Schratzberger, et al.. (2019). Immunosuppression after renal transplantation. memo - Magazine of European Medical Oncology. 12(3). 216–221. 20 indexed citations
16.
Pirklbauer, Markus, et al.. (2018). Giant cell arteritis as unusual cause of critical arm ischemia. Journal of Vascular Surgery Cases and Innovative Techniques. 4(3). 248–251. 2 indexed citations
17.
Pirklbauer, Markus, et al.. (2012). Oncostatin M inhibits TGF-β1-induced CTGF expression via STAT3 in human proximal tubular cells. Biochemical and Biophysical Research Communications. 424(4). 801–806. 21 indexed citations
18.
Pirklbauer, Markus & Gert Mayer. (2011). The exchangeable calcium pool: physiology and pathophysiology in chronic kidney disease. Nephrology Dialysis Transplantation. 26(8). 2438–2444. 19 indexed citations
19.
Schramek, Herbert, Andreas Kronbichler, Markus Pirklbauer, et al.. (2009). Neuropilin-1 and neuropilin-2 are differentially expressed in human proteinuric nephropathies and cytokine-stimulated proximal tubular cells. Laboratory Investigation. 89(11). 1304–1316. 28 indexed citations
20.
Perco, Paul, Kathrin Hochegger, Markus Pirklbauer, et al.. (2008). Bortezomib-Induced Survival Signals and Genes in Human Proximal Tubular Cells. Journal of Pharmacology and Experimental Therapeutics. 327(3). 645–656. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ernest Suresh Breakdown of academic impact, for papers by Peale Chuang Breakdown of academic impact, for papers by Pablo Íñigo Breakdown of academic impact, for papers by Taner Demirci Breakdown of academic impact, for papers by Panagiotis Pateinakis Breakdown of academic impact, for papers by Lara Matilla Breakdown of academic impact, for papers by Marianne Wigger Breakdown of academic impact, for papers by Nancy Wassef Breakdown of academic impact, for papers by Hiromichi Yoshizawa Breakdown of academic impact, for papers by Wencong Guo
Rankless by CCL
2026